TAIPEI, Sept. 6, 2020 /PRNewswire/ -- ACT Genomics is pleased to announce the completion of the first closing of the latest round of equity financing from a group of strategic investors including Aflac Ventures LLC and Kyoto University Innovation Capital. "We are very pleased to have...
from PR Newswire: https://ift.tt/2DzeIf9
No comments:
Post a Comment